The Motley Fool

Key Data Points

Primary metrics and data points about Theravance, Inc..
Current Price: $14.70
Prev Close: $14.30
Open: $14.61
Bid: $14.60
Ask: $14.63
Day's Range: $13.72 - $14.67
52wk Range: $10.58 - $23.84
Volume: 348,559
Avg Vol 613,307
Market Cap: $2B
P/E (ttm): -29.18
EPS (ttm): ($0.49)
Div & Yield: $1.00 (7.0%)

Business Summary

Industry, sector and description for Theravance, Inc..

A biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

THRX vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Theravance, Inc..
CAPS Rating 3 out of 5
96 Outperform
31 Underperform
CAPS All Stars
38 Outperform
6 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Rick E. Winningham, CEO

100% Approve

Based on 3 Ratings

More Details for TheravanceJobs

Powered by

More Details about Theravance, Inc.

Primary metrics and data points about Theravance, Inc..